As of 2025-03-19, the EV/EBITDA ratio of Adapthealth Corp (AHCO) is -50.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AHCO's latest enterprise value is 3,261.77 mil USD. AHCO's TTM EBITDA according to its financial statements is -64.72 mil USD. Dividing these 2 quantities gives us the above AHCO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 7.7x | 6.2x |
| Forward P/E multiples | 10.6x - 14.5x | 12.3x |
| Fair Price | (16.29) - 47.90 | 10.60 |
| Upside | -262.5% - 378.0% | 5.8% |
| Date | EV/EBITDA |
| 2025-03-18 | -50.11 |
| 2025-03-17 | -49.82 |
| 2025-03-14 | -49.53 |
| 2025-03-13 | -49.55 |
| 2025-03-12 | -49.38 |
| 2025-03-11 | -50.61 |
| 2025-03-10 | -51.32 |
| 2025-03-07 | -51.36 |
| 2025-03-06 | -51.92 |
| 2025-03-05 | -51.28 |
| 2025-03-04 | -51.07 |
| 2025-03-03 | -52.44 |
| 2025-02-28 | -53.23 |
| 2025-02-27 | -52.63 |
| 2025-02-26 | -52.65 |
| 2025-02-25 | -51.69 |
| 2025-02-24 | -47.34 |
| 2025-02-21 | -47.13 |
| 2025-02-20 | -47.80 |
| 2025-02-19 | -48.27 |
| 2025-02-18 | -47.73 |
| 2025-02-14 | -47.82 |
| 2025-02-13 | -48.13 |
| 2025-02-12 | -48.17 |
| 2025-02-11 | -48.67 |
| 2025-02-10 | -48.60 |
| 2025-02-07 | -48.96 |
| 2025-02-06 | -49.65 |
| 2025-02-05 | -50.71 |
| 2025-02-04 | -50.53 |
| 2025-02-03 | -50.86 |
| 2025-01-31 | -52.07 |
| 2025-01-30 | -51.84 |
| 2025-01-29 | -51.67 |
| 2025-01-28 | -51.78 |
| 2025-01-27 | -52.51 |
| 2025-01-24 | -51.05 |
| 2025-01-23 | -50.90 |
| 2025-01-22 | -50.71 |
| 2025-01-21 | -51.40 |
| 2025-01-17 | -51.44 |
| 2025-01-16 | -51.15 |
| 2025-01-15 | -51.05 |
| 2025-01-14 | -51.13 |
| 2025-01-13 | -51.05 |
| 2025-01-10 | -50.65 |
| 2025-01-08 | -50.57 |
| 2025-01-07 | -50.44 |
| 2025-01-06 | -49.40 |
| 2025-01-03 | -49.61 |